Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.

@article{Codde2018RiskOP,
  title={Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.},
  author={E Codde and Aime Munro and C J R Stewart and Katrina Spilsbury and Shirley Bowen and Jim Codde and Nerida Steel and Yee Leung and Jason Jit-Sun Tan and Stuart G Salfinger and Ganendra Raj Kader Ali Mohan and Paul A Cohen},
  journal={BJOG : an international journal of obstetrics and gynaecology},
  year={2018},
  volume={125 1},
  pages={74-79}
}
OBJECTIVE To compare outcomes of patients with pure adenocarcinoma-in-situ (AIS) and mixed AIS/CIN 2/3 lesions including the incidence of AIS persistence, recurrence and progression to adenocarcinoma. DESIGN Retrospective cohort study. SETTING Statewide population in Western Australia. POPULATION Women diagnosed with AIS between 2001 and 2012. METHODS We conducted a retrospective, population-based cohort study. MAIN OUTCOME MEASURES De-identified linked data were utilised to ascertain… CONTINUE READING